Cancer Chemother Pharmacol 英文杂志缩写 - Cancer Chemotherapy and Pharmacology - 英文期刊全称 相关期刊: AACN Clinical Issues AACN Clinical Issues in Critical Care Nursing AADE Editors Journal AANA Journal AANNT Journal AAOHN Journal AAPPO Journal ...
Cancer Chemother Pharmacol. 2009 Jul 8. :Zhao L, Chen Z, Wang J, et al. Synergistic effect of 5- fluorouracil and the flavanoid oroxylin A on Hep... Li,Zhao,Zhen,... - 《Cancer Chemotherapy & Pharmacology》 被引量: 42发表: 2010年 Cancer Chemother. Pharmacol. 2011 neurotox 5-Fluorour...
网络肿瘤化疗药理学 网络释义 1. 肿瘤化疗药理学 ...一年后,又一篇科学论文正待发表于国际知名肿瘤杂志《肿瘤化疗药理学》(Cancer Chemother. Pharmacol.);此外,经过 … news.ziqiang.net|基于 1 个网页
2023 - 92 (1) A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis. January 01, 2023 [MEDLINE Abstract] Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-me...
January 01, 2023 [MEDLINE Abstract] Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells. January 01, 2023 [MEDLINE Abstract] SMAGP regulates doxorubicin sensitivity in triple-negative breast cancer cells via modulating mitochon...
cancer. Cancer Chemother Pharmacol, 2008,61(4):623-629. [12] Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin Versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol, 2008,9(3):215-221. ...
Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy, Cancer Chemother Pharmacol, 2006,57: 663–670. [14] HYPERLINK /publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2004/p226.htm /publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2004/p226.htm [15] HYPERLINK...
[13] Kodama T, Hasegawa M, Takanashi K, et al. Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases. Cancer Chemother Pharmacol 2014;74:1023-8. [14] Lin NU, Prowell T, Tan AR, et al. Modernizing Clinical Trial Eligibility Criteria: Recommendations ...
Cancer Chemother. Pharmacol. 2010; 65 :1131–1136. doi: 10.1007/s00280-009-1121-7. [ Cross Ref ]Bark H, Choi CH (2010) PSC833, cyclosporine ... H Bark,CH Choi - 《Cancer Chemother Pharmacol》 被引量: 83发表: 2010年 Analysis of feasibility and toxicity of concurrent chemoradiotherapy ...